This is a Angiotensin news story, published by New Atlas.
For more Angiotensin news, you can click here:
more Angiotensin newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from New Atlas, you can click here:
more news from New AtlasOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
lower epilepsy risk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest blood pressure medications news, blood pressure drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Epilepsy riskNew Atlas
•88% Informative
Epilepsy risk drops up to 30% on existing blood pressure drugs.
Study of 2.2 million Americans focused on 2 million people with high blood pressure.
Angiotensin receptor blockers (ARBs) had a reduced risk of developing epilepsy.
ARBs reduce blood pressure and decrease inflammation in blood vessels and organs, including the brain.
VR Score
90
Informative language
91
Neutral language
68
Article tone
semi-formal
Language
English
Language complexity
62
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
6
Affiliate links
no affiliate links